 DIAPRESAN D
|
Montpellier
|
| valsartán+hidroclorotiazida |
Antihipertensivo |
| 160/12.5 mg comp.rec.x30 | $33.449,05 | (19/12/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $15.557,92 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $19.399,94 AF $14.049,11 |
|
|
|
|
| 160/25 mg comp.rec.x30 | $41.339,44 | (19/12/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $18.028,03 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $24.255,32 AF $17.084,12 |
|
|
|
|
| 320/12.5 mg comp.rec.x30 | $43.566,41 | (19/12/25) |
| PAMI |
|
| AF $17.034,19 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $25.063,23 AF $18.503,18 |
|
|
|
|
| 320/25 mg comp.rec.x30 | $43.832,45 | (19/12/25) |
|
|
|
| 80/12.5 mg comp.rec.x 30 | $28.315,56 | (19/12/25) |
| SIFAR |
Producto Reconocido |
|
| PAMI |
|
| AF $12.087,64 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $17.759,00 AF $10.556,56 |
|
|
|
|
| |
